This unique feature imparts antioxidant protection to noncancerous tissues, making DAP compounds a potentially safe inhibitor for EV regulating oncogenic proteins (STAT3, FAS, and TMEM205), with applications in preventing obesity-mediated EC and other cancers within an obese microenvironment. The gene discussed is FAS; the disease is obesity due to melanocortin 4 receptor deficiency.